XML 30 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Dec. 22, 2017
Mar. 30, 2016
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Sep. 30, 2017
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Textual)              
Common stock, shares issued     10,677,222   10,677,222   8,345,844
Goodwill     $ 1,586,796   $ 1,586,796   $ 1,586,796
Research and development     $ 778,856 $ 190,648 $ 4,825,230 $ 2,461,722  
Maximum [Member]              
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Textual)              
U.S. corporate tax rate 35.00%            
Minimum [Member]              
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Textual)              
U.S. corporate tax rate 21.00%            
Leonard-Meron Biosciences, Inc. [Member]              
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Textual)              
Common stock, shares issued   1,942,456          
Intangible assets   $ 19,400,000          
Goodwill   1,586,796          
Excess purchase price   19,015,073          
Assets acquired   17,428,277          
Research and development   $ 17,428,277          
Amortized on straight-line basis period   8 years